Consequences of delayed therapy with second-line agents in rheumatoid arthritis: a 3 year followup on the hydroxychloroquine in early rheumatoid arthritis (HERA) study.

Source:http://linkedlifedata.com/resource/pubmed/id/10743799

Download in:

View as

General Info

PMID
10743799